Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Testosterone may slow down wound healing and increase inflammation.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Finasteride helps reduce heart issues and improves heart function.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.